Roche And ReMYND Enter Into A Strategic Alliance To Develop First-In-Class Disease-Modifying Treatments For Parkinson's And Alzheimer's Disease

Cognitive Impairment In People With Parkinson's Disease Exposed By Study

Santhera And Ipsen Enter Into Licensing Agreement For Fipamezole For The Treatment Of Dyskinesia In Parkinson's Disease

New Light On The Mechanism Of Parkinson's Disease

New Parkinson's Gene Is Linked To Immune System

Impax Pharmaceuticals Completes Enrollment In ADVANCE-PD Phase III Trial Of IPX066 In Parkinson's Disease

Lipid Peroxides, More Sophisticated Than Their Reputation

Alnylam And Collaborators Publish New Pre-Clinical Research On Therapeutic Silencing Of Parkinson's Disease Gene

A Promising Target For Developing Treatments Against Parkinson's Disease

A Promising Target For Developing Treatments Against Parkinson's Disease

Brain Connections Break Down As We Age

Human Induced Pluripotent Stem Cells Successfully Used To Treat Parkinson's In Rodents

Genetic Link Discovered Between Immune System, Parkinson's Disease

Immune System Genes Linked To Parkinson's Disease

Development Of Neurochip Technology Will Further Brain Research Of Alzheimer's, Parkinson's

TEMPO Study Further Demonstrates The Benefits Of Azilect® In Early Parkinson's Disease Patients

Expectations May Affect Placebo Response In Patients With Parkinson's Disease

TEMPO Extentension Study Further Demonstrates The Benefits Of Azilect® In Early Parkinson's Disease Patients

New Pathway To Parkinson's And Alzheimer's Diseases

Study Identifies Molecular Mechanism Triggering Parkinson's Disease

REM Sleep Disorder Could Be Early Warning Of Parkinson's, Dementia That Develops Decades Later

Envoy To Seek New Parkinson's Disease Therapy With Scripps

Helping Neurons Fix Themselves In Parkinson's Patients

New Partnership With Open-Access Journal Molecular Neurodegeneration Announced By American Health Assistance Foundation

Every Action Has A Beginning And An End (And It's All In Your Brain)